{"name": "Takeda Pharmaceutical",
 "permalink": "takeda-pharmaceutical",
 "crunchbase_url": "http://www.crunchbase.com/company/takeda-pharmaceutical",
 "homepage_url": "http://www.takeda.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "81 6 6204 2111",
 "description": "",
 "created_at": "Tue Sep 08 01:14:48 UTC 2009",
 "updated_at": "Thu Dec 22 04:14:09 UTC 2011",
 "overview": "\u003Cp\u003ETakeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company in Japan. \u003C/p\u003E\n\n\u003Cp\u003EThe company markets its original products, such as the anti-prostatic cancer agent leuprolide acetate (marketed as Lupron Depot, Enantone, Prostap, and Leuplin), the anti-peptic ulcer agent lansoprazole (marketed as Prevacid, Ogast, Takepron, and other names), the anti-hypertensive agent candesartan cilexetil (marketed as Blopress, Kenzen, and Amias), and the anti-diabetic agent pioglitazone hydrochloride (marketed as Actos). Segments The company operates its business in two categories, Pharmaceutical business and Other businesses. The Pharmaceutical business represents the ethical drug business and healthcare business.\u003C/p\u003E\n\n\u003Cp\u003EOther businesses include business activities involving the production and marketing of a range of products, including vitamin bulks, test reagents \u0026amp; clinical diagnostics, photographic chemicals, and inorganic chemicals. \u003C/p\u003E\n\n\u003Cp\u003EHistory Takeda Pharmaceutical Company Limited was founded in 1781.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[82,
       32],
      "assets/images/resized/0005/9044/59044v2-max-150x150.png"],
     [[82,
       32],
      "assets/images/resized/0005/9044/59044v2-max-250x250.png"],
     [[82,
       32],
      "assets/images/resized/0005/9044/59044v2-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [{"funding_round":
     {"round_code": "unattributed",
      "source_url": "http://www.masshightech.com/stories/2011/03/28/daily4-Alnylam-lands-10M-pay-from-Takeda.html",
      "source_description": "Alnylam lands $10M pay from Takeda",
      "raised_amount": 10000000.0,
      "raised_currency_code": "USD",
      "funded_year": 2011,
      "funded_month": 3,
      "funded_day": 28,
      "company":
       {"name": "Alnylam Pharmaceuticals",
        "permalink": "alnylam-pharmaceuticals-2",
        "image":
         {"available_sizes":
           [[[150,
              40],
             "assets/images/resized/0012/8181/128181v1-max-150x150.png"],
            [[173,
              47],
             "assets/images/resized/0012/8181/128181v1-max-250x250.png"],
            [[173,
              47],
             "assets/images/resized/0012/8181/128181v1-max-450x450.png"]],
          "attribution": null}}}}],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": 8689310000.0,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://www.takeda.com/press/article_29939.html",
    "source_description": "Takeda Completes Acquisition of Millennium",
    "acquired_year": 2008,
    "acquired_month": 2,
    "acquired_day": 1,
    "company":
     {"name": "Millennium Pharmaceuticals",
      "permalink": "millennium-pharmaceuticals",
      "image":
       {"available_sizes":
         [[[150,
            51],
           "assets/images/resized/0005/8968/58968v1-max-150x150.png"],
          [[177,
            61],
           "assets/images/resized/0005/8968/58968v1-max-250x250.png"],
          [[177,
            61],
           "assets/images/resized/0005/8968/58968v1-max-450x450.png"]],
        "attribution": null}}},
   {"price_amount": null,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "",
    "source_description": "Cap Funding Report",
    "acquired_year": 2008,
    "acquired_month": 2,
    "acquired_day": 1,
    "company":
     {"name": "Takeda Bio Development Center",
      "permalink": "takeda-bio-development-center",
      "image":
       {"available_sizes":
         [[[150,
            10],
           "assets/images/resized/0006/1356/61356v1-max-150x150.jpg"],
          [[250,
            17],
           "assets/images/resized/0006/1356/61356v1-max-250x250.jpg"],
          [[360,
            25],
           "assets/images/resized/0006/1356/61356v1-max-450x450.jpg"]],
        "attribution": null}}},
   {"price_amount": 310000000.0,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://www.intellikine.com/pdf/Intellikine_PressRelease_Dec20_2011.pdf",
    "source_description": "Takeda to Acquire Intellikine, Adding Two Novel Programs to its Oncology Pipeline",
    "acquired_year": 2011,
    "acquired_month": 12,
    "acquired_day": 21,
    "company":
     {"name": "Intellikine",
      "permalink": "intellikine",
      "image":
       {"available_sizes":
         [[[150,
            29],
           "assets/images/resized/0005/4526/54526v1-max-150x150.jpg"],
          [[234,
            46],
           "assets/images/resized/0005/4526/54526v1-max-250x250.jpg"],
          [[234,
            46],
           "assets/images/resized/0005/4526/54526v1-max-450x450.jpg"]],
        "attribution": null}}},
   {"price_amount": null,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://www.marketwatch.com/story/takeda-to-acquire-inviragen-inc-2013-05-07",
    "source_description": "Takeda to Acquire Inviragen, Inc.",
    "acquired_year": 2013,
    "acquired_month": 5,
    "acquired_day": 7,
    "company":
     {"name": "Inviragen",
      "permalink": "inviragen",
      "image":
       {"available_sizes":
         [[[150,
            82],
           "assets/images/resized/0006/2054/62054v1-max-150x150.jpg"],
          [[167,
            92],
           "assets/images/resized/0006/2054/62054v1-max-250x250.jpg"],
          [[167,
            92],
           "assets/images/resized/0006/2054/62054v1-max-450x450.jpg"]],
        "attribution": null}}}],
 "offices":
  [{"description": "",
    "address1": "1-1 Doshomachi 4-chome",
    "address2": "Chuo-ku",
    "zip_code": "540-8645",
    "city": "Osaka",
    "state_code": null,
    "country_code": "JPN",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Takeda adds $1.5B for new drug buys",
    "stoned_year": 2010,
    "stoned_month": 7,
    "stoned_day": 8,
    "source_url": "http://www.fiercebiotech.com/story/takeda-adds-1-5b-new-drug-buys/2010-07-08?utm_medium=rss\u0026utm_source=rss",
    "source_text": "",
    "source_description": "Takeda adds $1.5B for new drug buys",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Takeda Pharmaceutical",
      "permalink": "takeda-pharmaceutical"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  [{"external_url": "http://takedajobs.com/",
    "title": "Takeda sales jobs"}]}